Literature DB >> 11464901

Detailed molecular analysis of 1p36 in neuroblastoma.

P S White1, P M Thompson, B A Seifried, E P Sulman, S J Jensen, C Guo, J M Maris, M D Hogarty, C Allen, J A Biegel, T C Matise, S G Gregory, C P Reynolds, G M Brodeur.   

Abstract

BACKGROUND: Several lines of evidence es tablish that chromosome band 1p36 is frequently deleted in neuroblastoma primary tumors and cell lines, suggesting that a tumor suppressor gene within this region is involved in the development of this tumor. PROCEDURE: We analyzed the status of 1p36 in primary neuroblastomas and cell lines to define the region of consistent rearrangement.
RESULTS: Loss of heterozygosity (LOH) studies of primary neuro blastomas identified allelic loss in 135 of 503 tumors (27%), with the smallest region of overlap (SRO) defined distal to D15214 (1p36.3). No homozygous deletions were detected at 120 loci mapping to 1p36.1-p36.3 in a panel of 46 neuroblastoma cell lines. A recently identified patient with neuroblastoma was found to have a constitutional deletion within 1p36.2-p36.3, and this deletion, when combined with the LOH results, defined a smaller SRO of one megabase within 1p36.3. We constructed a comprehensive integrated map of chromosome 1 containing 11,000 markers and large-insert clones, a high-resolution radiation hybrid (RH) map of 1p36, and a P1-artificial chromosome (PAC) contig spanning the SRO, to further characterize the region of interest. Over 768 kb (75%) of the SRO has been sequenced to completion. Further analysis of distal 1p identified 113 transcripts localizing to 1p36, 21 of which were mapped within the SRO.
CONCLUSION: This analysis will identify suitable positional candidate transcripts for mutational screening and subsequent identification of the 1p36.3 neuroblastoma suppressor gene.

Entities:  

Mesh:

Year:  2001        PMID: 11464901     DOI: 10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  17 in total

1.  A unique role of the DNA fragmentation factor in maintaining genomic stability.

Authors:  Bin Yan; Huili Wang; Yuanlin Peng; Ye Hu; He Wang; Xiuwu Zhang; Qi Chen; Joel S Bedford; Mark W Dewhirst; Chuan-Yuan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.

Authors:  Elisabetta Benedetti; Renato Galzio; Barbara D'Angelo; Maria Paola Cerù; Annamaria Cimini
Journal:  PPAR Res       Date:  2010-03-17       Impact factor: 4.964

3.  KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.

Authors:  Arasambattu K Munirajan; Kiyohiro Ando; Akira Mukai; Masato Takahashi; Yusuke Suenaga; Miki Ohira; Tadayuki Koda; Toru Hirota; Toshinori Ozaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

Review 4.  Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.

Authors:  Kristopher R Bosse; John M Maris
Journal:  Cancer       Date:  2015-11-05       Impact factor: 6.860

Review 5.  Research progress of neuroblastoma related gene variations.

Authors:  Yanna Cao; Yan Jin; Jinpu Yu; Jingfu Wang; Jie Yan; Qiang Zhao
Journal:  Oncotarget       Date:  2017-03-14

6.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

7.  A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.

Authors:  Helena Carén; Katarina Ejeskär; Susanne Fransson; Luke Hesson; Farida Latif; Rose-Marie Sjöberg; Cecilia Krona; Tommy Martinsson
Journal:  Mol Cancer       Date:  2005-03-01       Impact factor: 27.401

8.  CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.

Authors:  Tomoyuki Fujita; Jun Igarashi; Erin R Okawa; Takahiro Gotoh; Jayanthi Manne; Venkatadri Kolla; Jessica Kim; Huaqing Zhao; Bruce R Pawel; Wendy B London; John M Maris; Peter S White; Garrett M Brodeur
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

9.  High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Authors:  Helena Carén; Jennie Erichsen; Linda Olsson; Charlotta Enerbäck; Rose-Marie Sjöberg; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
Journal:  BMC Genomics       Date:  2008-07-29       Impact factor: 3.969

10.  Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.

Authors:  Chao Qin; Xiaoyan He; Yanding Zhao; Chun-Yip Tong; Kenneth Y Zhu; Yongqi Sun; Chao Cheng
Journal:  BMC Med Genomics       Date:  2019-12-12       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.